Correlation Between Antisense Therapeutics and Ravenquest Biomed

Can any of the company-specific risk be diversified away by investing in both Antisense Therapeutics and Ravenquest Biomed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antisense Therapeutics and Ravenquest Biomed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Antisense Therapeutics Limited and Ravenquest Biomed, you can compare the effects of market volatilities on Antisense Therapeutics and Ravenquest Biomed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antisense Therapeutics with a short position of Ravenquest Biomed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antisense Therapeutics and Ravenquest Biomed.

Diversification Opportunities for Antisense Therapeutics and Ravenquest Biomed

0.0

Correlation Coefficient

Antisense Therapeutics  Ravenquest Biomed

Pay attention - limited upside

The 3 months correlation between Antisense and Ravenquest is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Antisense Therapeutics Limited and Ravenquest Biomed in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ravenquest Biomed and Antisense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antisense Therapeutics Limited are associated (or correlated) with Ravenquest Biomed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ravenquest Biomed has no effect on the direction of Antisense Therapeutics i.e., Antisense Therapeutics and Ravenquest Biomed go up and down completely randomly.

Pair Corralation between Antisense Therapeutics and Ravenquest Biomed

If you would invest  0.00  in Ravenquest Biomed on September 20, 2024 and sell it today you would earn a total of  0.00  from holding Ravenquest Biomed or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Antisense Therapeutics Limited  vs.  Ravenquest Biomed

Antisense Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Antisense Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward-looking indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Ravenquest Biomed

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ravenquest Biomed has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Ravenquest Biomed is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Antisense Therapeutics and Ravenquest Biomed

The main advantage of trading using opposite Antisense Therapeutics and Ravenquest Biomed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antisense Therapeutics position performs unexpectedly, Ravenquest Biomed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ravenquest Biomed will offset losses from the drop in Ravenquest Biomed's long position.

The idea behind Antisense Therapeutics Limited and Ravenquest Biomed pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.